AMSペニールインプラントインフレータブル型モデル700の臨床試験成績

Abstract

器質性インポテンスと混合型インポテンス患者計34名に対し, AMSペニールインプラントインフレータブル型モデル700をインプラントした.1)患者の満足度は, 非常に満足23例(67.7%), 満足7例(20.6%), やや不満3例(8.8%), 悪化1例(2.9%)であった.2)重度の合併症は2例に生じた.2例とも感染によるもので, 最終的には2例ともプロステーシスを抜去した.3)有用性の評価はきわめて有用26例(76.5%), 有用7例(20.6%), 好ましくない1例(2.9%)であった

The AMS 700TM & 700 CXTM penile prosthesis was implanted in 34 organic and mixed-type impotent patients between November, 1984 and July, 1988. The patients' ages ranged between 32 and 70, with an average age of 57.2. Twelve weeks after implantation, the prosthesis was evaluated in terms of patient satisfaction with sexual intercourse and postoperative complications. Twenty three patients (67.7%) were highly satisfied, 7 (20.3%) satisfied, 3 (8.8%) dissatisfied and 1 patient worsened (2.9%). Severe complication was found in two cases, both of them being complicated by infection; as a result the prosthesis was removed. Utility of the prosthesis, e.g. effectiveness and safety was; high utility in 26 cases (76.5%), moderate utility in 7 cases (20.6%), and no favorable in one case (2.9%). Thus, overall effectiveness and safety of the AMS 700 penile prosthesis, with its excellent cosmetic appearance upon implantation, were demonstrated by the above findings.